Presentation is loading. Please wait.

Presentation is loading. Please wait.

Experimental sfrp1 manipulation causes complementary effects on non-myocardial marker gene expression. Experimental sfrp1 manipulation causes complementary.

Published byShinta Kusnadi Modified over 5 years ago

Similar presentations

Presentation on theme: "Experimental sfrp1 manipulation causes complementary effects on non-myocardial marker gene expression. Experimental sfrp1 manipulation causes complementary."— Presentation transcript:

1 Experimental sfrp1 manipulation causes complementary effects on non-myocardial marker gene expression. Experimental sfrp1 manipulation causes complementary effects on non-myocardial marker gene expression. (A-D) WISH analysis showing frizzled 7 (fzd7) expression (arrowheads) in CoMO-injected (A), sfrp1MO1-injected (B), non-transgenic control (C) and sfrp1-overexpressing transgenic (D) embryos, together with corresponding sections through the posterior pericardium. (G-J) WISH analysis showing gata5 expression (arrowheads) in CoMO (G), sfrp1MO1 (H), non-transgenic control (I) and sfrp1-overexpressing (J) embryos, with corresponding posterior pericardial sections. (E,F,K,L) Analysis of fzd7 (E,F) and gata5 (K,L) sections representing the number of pixels measured from the apex of the section to the edge of gene expression staining. CoMO compared with sfrp1MO1: n=4, ***P<0.001 (E,K). Non-transgenic control compared with sfrp1 overexpression: n=3, **P<0.01 (F,L). Data are mean ± s.e.m. Natalie Gibb et al. Development 2013;140: © Published by The Company of Biologists Ltd

Download ppt "Experimental sfrp1 manipulation causes complementary effects on non-myocardial marker gene expression. Experimental sfrp1 manipulation causes complementary."

Similar presentations

Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn. Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn.

Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn. Vegetal RNAs antagonise the dorsalising and BMP-inhibiting activity of Vrtn.
SESN2 expression in lungs from healthy donors, habitual smokers without COPD and individuals with late-stage COPD. (A) Representative western blots of.

SESN2 expression in lungs from healthy donors, habitual smokers without COPD and individuals with late-stage COPD. (A) Representative western blots of.
Ocular defects produced by Daam1 mutation and in combination with diabetes. Ocular defects produced by Daam1 mutation and in combination with diabetes.

Ocular defects produced by Daam1 mutation and in combination with diabetes. Ocular defects produced by Daam1 mutation and in combination with diabetes.
Fig. 4. Expression of oxt is undetectable in the med12 mutant but is unaffected by treatment with Wnt inhibitors. Expression of oxt is undetectable in.

Fig. 4. Expression of oxt is undetectable in the med12 mutant but is unaffected by treatment with Wnt inhibitors. Expression of oxt is undetectable in.
Fig. 2. abu/pqn genes are expressed in the pharyngeal cuticle

Fig. 2. abu/pqn genes are expressed in the pharyngeal cuticle
Overexpression of cx43 rescues smc3-dependent skeletal phenotypes

Overexpression of cx43 rescues smc3-dependent skeletal phenotypes
Altered oligodendrocyte progenitor cell (OPC) marker protein expression in two white matter regions of ShhΔFP/ΔFP and SmoΔNT/ΔNT embryos at E15.5. Altered.

Altered oligodendrocyte progenitor cell (OPC) marker protein expression in two white matter regions of ShhΔFP/ΔFP and SmoΔNT/ΔNT embryos at E15.5. Altered.
Fig. 6. Cross-section of the stomach wall and spiral intestine of the embryo, stained with PAS. (A) Surface of the stomach wall (SW) and ingested material.

Fig. 6. Cross-section of the stomach wall and spiral intestine of the embryo, stained with PAS. (A) Surface of the stomach wall (SW) and ingested material.
A subset of Trp53CKO fiber cells fail to exit the cell cycle, but express fiber-cell-specific markers. A subset of Trp53CKO fiber cells fail to exit the.

A subset of Trp53CKO fiber cells fail to exit the cell cycle, but express fiber-cell-specific markers. A subset of Trp53CKO fiber cells fail to exit the.
Tomoregulin-1 improves cardiac morphology and function after pressure overload. Tomoregulin-1 improves cardiac morphology and function after pressure overload.

Tomoregulin-1 improves cardiac morphology and function after pressure overload. Tomoregulin-1 improves cardiac morphology and function after pressure overload.
Tomoregulin-1 improves cardiac pathological changes after pressure overload. Tomoregulin-1 improves cardiac pathological changes after pressure overload.

Tomoregulin-1 improves cardiac pathological changes after pressure overload. Tomoregulin-1 improves cardiac pathological changes after pressure overload.
Expression of Shh-Gli target genes in astrocyte progenitors.

Expression of Shh-Gli target genes in astrocyte progenitors.
Tbx1 regulates the Mef2c AHF enhancer in vivo.

Tbx1 regulates the Mef2c AHF enhancer in vivo.
Embryonic corneal defects in E18.5 AP-2β NCC KO mutant embryos.

Embryonic corneal defects in E18.5 AP-2β NCC KO mutant embryos.
Altered progenitor domain marker protein expression in ShhΔFP/ΔFP embryos at E12.5. Altered progenitor domain marker protein expression in ShhΔFP/ΔFP embryos.

Altered progenitor domain marker protein expression in ShhΔFP/ΔFP embryos at E12.5. Altered progenitor domain marker protein expression in ShhΔFP/ΔFP embryos.
Tomoregulin-1 inhibits the TGFβ non-canonical (TAK1-JNK) pathways after pressure overload. Tomoregulin-1 inhibits the TGFβ non-canonical (TAK1-JNK) pathways.

Tomoregulin-1 inhibits the TGFβ non-canonical (TAK1-JNK) pathways after pressure overload. Tomoregulin-1 inhibits the TGFβ non-canonical (TAK1-JNK) pathways.
Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse myocardium. Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse.

Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse myocardium. Expression of tomoregulin-1 in wild-type and cardiac hypertrophy mouse.
Table 2. Cell surface abundance of β1 integrin measured by flow cytometry.DDR wild type and DDR over-expressing cells were treated with deoxymannojirimycin.

Table 2. Cell surface abundance of β1 integrin measured by flow cytometry.DDR wild type and DDR over-expressing cells were treated with deoxymannojirimycin.
Ectopic sprouting and proliferation in Rbpj veins.

Ectopic sprouting and proliferation in Rbpj veins.
DHR3 suppresses Phm protein levels.

DHR3 suppresses Phm protein levels.

Similar presentations

Ads by Google